ScreenCell® Marks Shipment of 50,000 units for Characterization of Circulating Tumor Cells
Published on June 13th, 2014
ScreenCell is a fully disposable, self-contained separation device that removes all blood components from CTCs, based on size differential. “We provide a customized solution to research sites that include optimum transportation of patent samples, rapid cell separation, and validated protocols for characterization.” said Georges Uzan, CSO of ScreenCell.
ScreenCell’s patented design supports a complete set of downstream analyses, including cell culture and identification of most aggressive CTC subpopulations.
